Clovis Oncology Raising $170M in Public Offering
Boulder-based Clovis Oncology, has filed to raise another $170M in a public offering, according to a filing by the firm Monday. The biopharmaceuticals firm, which develops anti-cancer drugs, trades on the NASDAQ Global Select Market as CLVS. The firm had its IPO back in 2011.
posted on Tuesday, June 11, 2013
Related companies:
Clovis Oncology
Related stories:
> Clovis Oncology Raises $130M In IPO
> Clovis Oncology Prices IPO
> Clovis Oncology Files For IPO
> Clovis Oncology On Tap For IPO
> Clovis Oncology Raises $145M
Techrockies.com Home